Distribución geográfica de la enfermedad de Kawasaki en Chile

Hoyos-Bachiloglu, Rodrigo; García, Adán Pérez; Morales, Pamela S.; Cerda, Jaime; Talesnik, Eduardo; Borzutzky, Arturo

doi:10.4067/s0716-10182016000100002

Cited by 5 publications

(5 citation statements)

References 31 publications

(34 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Epidemiologic studies are rare in most European countries, and the incidence of KD has been reported as less than 17.6 per 100,000 less than 5-year-olds [20], remaining stationary without significant increases or decreases as in North America [4,21,22]. In Latin America, no systematic epidemiological study of KD has been performed in each country, although the incidence of KD has been reported sporadically in several countries [23,24]. The recently founded Latin American Kawasaki Disease Network (REKAMLATINA) is expected to improve the understanding of KD epidemiology in Latin America.…”

Section: Global Incidence Of Kdmentioning

confidence: 99%

Reality of Kawasaki disease epidemiology

Kim

2019

Korean J Pediatr

View full text Add to dashboard Cite

Epidemiologic studies of Kawasaki disease (KD) have shown a new pattern or change of its occurrence suggestive of its pathophysiology or risk factors from the first patient with KD reported in 1961. The incidence of KD in Northeast Asian countries including Japan, South Korea, China, and Taiwan is 10–30 times higher than that in the United States and Europe. Knowing the true epidemiology of KD in each country and the availability of publications of KD epidemiology also could benefit general health care providers and general population. This would enable the early detection and treatment of KD, ultimately reducing the incidence of coronary artery complications and mortality. Therefore, efforts to investigate the true epidemiology of KD should be continued in every country using a questionnaire survey, National Health Insurance system data, or combined methods depending on each country’s medical environment to ensure high-quality care of patients with KD.

show abstract

Section: Global Incidence Of Kdmentioning

confidence: 99%

Reality of Kawasaki disease epidemiology

Kim

2019

Korean J Pediatr

View full text Add to dashboard Cite

show abstract

“…Respecto de la epidemiología de la EK en Chile, los datos presentados en este estudio muestran que durante el período analizado no se registraron cambios significativos en las tasas de hospitalización por EK al compararlas con estudios previos 7,10 . La tasa de hospitalización en niños bajo 5 años, considerando 10% de re-hospitalizaciones, fue de 9,5 casos por 100.000 (IC 95% 8,9-10), lo que no demostró cambios significativos en las tasas nacionales de hospitalizaciones por EK desde el año 2008 y se condice con lo reportado en la literatura médica para países no pertenecientes a Asia (10-20 por cada 100.000 habs.…”

Section: Discussionunclassified

“…La epidemiología de la EK en Chile también ha sido estudiada mediante el análisis de egresos hospitalarios, observándose un aumento de las hospitalizaciones por esta causa desde 9,3 por 100.000 entre 2005 y 2007 hasta 10,4 por 100.000 entre 2009 y 2011 en pacientes bajo 5 años. Desde entonces no hay nuevos reportes sobre la epidemiología de la EK en nuestro país 7,10 .…”

Section: Investigación Clínicaunclassified

Asociación temporal entre la circulación de virus respiratorios y hospitalizaciones por enfermedad de Kawasaki

Aguirre

Cerda

Perret

et al. 2021

Rev. chil. infectol.

Self Cite

View full text Add to dashboard Cite

Introducción: La etiología de la enfermedad de Kawasaki (EK) es desconocida, planteándose que infecciones virales la gatillan en pacientes susceptibles. Objetivo: Estudiar la asociación temporal entre la circulación de virus respiratorios y hospitalizaciones por EK en la Región Metropolitana (RM), Chile, entre 2010-2017. Metodología: Estudio ecológico retrospectivo de casos de EK en pacientes bajo 18 años de edad, en base a egresos hospitalarios. La circulación de virus se analizó mediante el reporte de la red de vigilancia metropolitana. Se utilizaron promedios móviles para EK (PMEK) y virus respiratorios (PMVR). Resultados: Se registraron 14.902 casos de infecciones virales respiratorias entre 2010-2017. Se observó correlación directa entre PMVR-virus respiratorio sincicial (VRS) de un mes y año y PMEK del mes subsiguiente (coeficiente de correlación (ρ) = +0,441; p < 0,001), y una asociación similar para PMVR-influenza A (FLU A) (ρ = +0,362; p < 0,001). PMVR-influenza B (FLU B) y PMVRmetapneumovirus (MPV) presentan correlaciones directas con PMEK (ρ = +0,443; p < 0,001 y ρ = +0,412; p < 0,001, respectivamente), siendo contemporáneo en mes y año con EK para FLU B, mientras que MPV presenta un desfase de un mes entre PMVR y PMEK. Conclusión: Existe correlación temporal directa entre la circulación de VRS, FLU A, FLU B y MPV con EK en niños de la RM, Chile.

show abstract

“…For precise estimation of disease burden, a research network was officially formed in 2013 comprising of 20 countries ( 78 ). Using the nationwide hospital-based data, the incidence of KD in Chilean children <5 years of age was estimated to be 5.7/100,000 in 2001–2004, 8.4/100,000 in 2005–2007, and 10.4/100,000 in 2009–2011 ( 79 , 80 ). The highest incidence of KD (19.8/100,000) was noted in Eastern Metropolitan Health District region that, notably, had the highest socioeconomic status in the country ( 80 ).…”

Section: Trend Of Incidencementioning

confidence: 99%

What Lies Ahead for Young Hearts in the 21st Century – Is It Double Trouble of Acute Rheumatic Fever and Kawasaki Disease in Developing Countries?

Banday

Mondal

Barman

et al. 2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Rheumatic heart disease (RHD), the principal long-term sequel of acute rheumatic fever (ARF), has been a major contributor to cardiac-related mortality in general population, especially in developing countries. With improvement in health and sanitation facilities across the globe, there has been almost a 50% reduction in mortality rate due to RHD over the last 25 years. However, recent estimates suggest that RHD still results in more than 300,000 deaths annually. In India alone, more than 100,000 deaths occur due to RHD every year (Watkins DA et al., N Engl J Med, 2017). Children and adolescents (aged below 15 years) constitute at least one-fourth of the total population in India. Besides, ARF is, for the most part, a pediatric disorder. The pediatric population, therefore, requires special consideration in developing countries to reduce the burden of RHD. In the developed world, Kawasaki disease (KD) has emerged as the most important cause of acquired heart disease in children. Mirroring global trends over the past two decades, India also has witnessed a surge in the number of cases of KD. Similarly, many regions across the globe classified as “high-risk” for ARF have witnessed an increasing trend in the incidence of KD. This translates to a double challenge faced by pediatric health care providers in improving cardiac outcomes of children affected with ARF or KD. We highlight this predicament by reviewing the incidence trends of ARF and KD over the last 50 years in ARF “high-risk” regions.

show abstract

Distribución geográfica de la enfermedad de Kawasaki en Chile

Cited by 5 publications

References 31 publications

Reality of Kawasaki disease epidemiology

Reality of Kawasaki disease epidemiology

Asociación temporal entre la circulación de virus respiratorios y hospitalizaciones por enfermedad de Kawasaki

What Lies Ahead for Young Hearts in the 21st Century – Is It Double Trouble of Acute Rheumatic Fever and Kawasaki Disease in Developing Countries?

Contact Info

Product

Resources

About